Italia markets open in 3 hours 28 minutes

Psychemedics Corporation (PMD)

NasdaqCM - NasdaqCM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,5400-0,1400 (-5,22%)
Alla chiusura: 04:00PM EDT
2,5400 0,00 (0,00%)
Dopo ore: 06:48PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente2,6800
Aperto2,6125
Denaro0,0000 x 0
Lettera0,0000 x 0
Min-Max giorno2,5400 - 2,6400
Intervallo di 52 settimane2,0600 - 5,5900
Volume3.141
Media Volume8.998
Capitalizzazione14,746M
Beta (5 anni mensile)0,70
Rapporto PE (ttm)N/D
EPS (ttm)-0,7200
Prossima data utili07 mag 2024 - 13 mag 2024
Rendimento e dividendo (futuro)0,28 (10,59%)
Data ex dividendo24 mag 2023
Stima target 1AN/D
  • GlobeNewswire

    Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

    ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company's revenue generation and growth strategies. With an exceptional track record of leadership and a strong background in revenue growth and optimization, Shoemaker brings a wealth of experience to h

  • GlobeNewswire

    Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    ACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its newly appointed President and Chief Executive Officer, Brian Hullinger, upon his entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Mr. Hullinger received an inducement grant option to purchase up to 300,000 shares of common stock. The inducement awards wer

  • GlobeNewswire

    Psychemedics Corporation Reports Second Quarter 2023 Financial Results

    ACTON, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2023. The Company’s revenue for the quarter ended June 30, 2023, was $5.5 million versus $6.5 million for the quarter ended June 30, 2022, a decrease of 15%. Net loss for the quarter ended June 30, 2023, was $(726,000) or $(0.13) per diluted share, versus net loss of $(338,0